<DOC>
	<DOCNO>NCT03099590</DOCNO>
	<brief_summary>Participants enroll 14-week study ( 2 week baseline , 8 week treatment , 4 week follow-up ) investigate impact Alkontrol-herbal ( Isoflavone ; Kudzu ) alcohol intake population seek treatment alcohol use disorder .</brief_summary>
	<brief_title>Alkontrol-herbal Effects Alcohol Drinking</brief_title>
	<detailed_description>Over past 15 year , Behavioral Psychopharmacology Research Lab McLean Hospital extensively study kudzu extract demonstrate safety efficacy healthy control subject well heavy binge drinker . The relative success recent outpatient trial kudzu extract demonstrate modest decrease drinking , reduction number heavy drinking day , significant increase number day abstinent . This suggest Alkontrol-herbal , kudzu extract , may useful adjunct treat alcohol use disorder . Participants enroll 14-week study ( 2 week baseline , 8 week treatment , 4 week follow-up ) investigate impact Alkontrol-herbal alcohol intake population ( age 21-60 year ) seek treatment alcohol use disorder . Participants take 500 mg crude kudzu extract ( NPI-031 , Alkontrol-herbal ; Natural Pharmacia International , Burlington , MA ) t.i.d . ; match sugar beet placebo capsule serve placebo . Subjects come lab three time week provide urine sample test medication compliance biochemical marker , acetazolamide , include medication capsule . Participants record alcohol intake daily diary wrist actigraphy device , also monitor sleep/wake activity .</detailed_description>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Alcohol Abstinence</mesh_term>
	<mesh_term>Puerarin</mesh_term>
	<criteria>Subject understand comply protocol Good physical mental health ( normal physical exam , ECG , blood urine chemistry , include absence history laboratory evidence diabetes ) Body Mass Index 1830 , inclusive Age 2160 year ( age verify driver 's license valid form identification ) Meet criterion current Moderate Severe ( 4+ symptom ) Alcohol Use Disorder per DSM5 ; If attend selfhelp treatment group ( e.g. , AA ) time screen visit , subject must agree continue attend group duration study Seeking treatment Alcohol Use Disorder Drink 2035 ( ) drink per week Report drink 80 % day past 90 day Have stable living situation current postal address Subject meet DSM5 criterion major depression and/or bipolar disorder , medically , pharmacologically , clinically stable . Subjects currently meet criterion minor depression bipolar disorder clinically stable ( include medication ) past 2 month may participate study , investigator 's discretion Concurrent diagnosis Axis I disorder , include substance use disorder besides alcohol use disorder Maintained antipsychotic antiseizure medication ; Current prescription benzodiazepine Presence neurological , infectious , neoplastic disease chronic medical disorder Tobacco use great 10 cigarette per day Currently abstain consume alcoholic beverage longer 10 day History major head trauma result cognitive impairment history seizure disorder Heavy caffeine use ( great 500 mg regular , daily basis ) Subject active hepatitis and/or aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) &gt; 3x upper limit normal For female volunteer , positive pregnancy test ( female subject must agree approve method contraception duration study )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>